GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (OSTO:IMMU) » Definitions » ROC (Joel Greenblatt) %

Mendus AB (OSTO:IMMU) ROC (Joel Greenblatt) % : -291.62% (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Mendus AB ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Mendus AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -291.62%.

The historical rank and industry rank for Mendus AB's ROC (Joel Greenblatt) % or its related term are showing as below:

OSTO:IMMU' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -63796.81   Med: -4444.64   Max: -172.65
Current: -327.27

During the past 13 years, Mendus AB's highest ROC (Joel Greenblatt) % was -172.65%. The lowest was -63796.81%. And the median was -4444.64%.

OSTO:IMMU's ROC (Joel Greenblatt) % is ranked worse than
50.99% of 1410 companies
in the Biotechnology industry
Industry Median: -307.695 vs OSTO:IMMU: -327.27

Mendus AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 37.50% per year.


Mendus AB ROC (Joel Greenblatt) % Historical Data

The historical data trend for Mendus AB's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mendus AB ROC (Joel Greenblatt) % Chart

Mendus AB Annual Data
Trend Jun14 Jun15 Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -987.26 -2,377.45 -4,836.85 -627.08 -172.65

Mendus AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -267.09 -289.49 -261.31 -458.55 -291.62

Competitive Comparison of Mendus AB's ROC (Joel Greenblatt) %

For the Biotechnology subindustry, Mendus AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mendus AB's ROC (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mendus AB's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Mendus AB's ROC (Joel Greenblatt) % falls into.



Mendus AB ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (5.857 + 0 + 12.954)
=-18.811

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.00099999999997635) - (5.666 + 0 + 15.255)
=-20.92

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Mendus AB for the quarter that ended in Sep. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-90.948/( ( (32.047 + max(-18.811, 0)) + (30.328 + max(-20.92, 0)) )/ 2 )
=-90.948/( ( 32.047 + 30.328 )/ 2 )
=-90.948/31.1875
=-291.62 %

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mendus AB  (OSTO:IMMU) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Mendus AB ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Mendus AB's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mendus AB Business Description

Traded in Other Exchanges
Address
Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.

Mendus AB Headlines

From GuruFocus

Immunomedics: A Solid Cancer Research Play

By Ishan Majumdar Ishan Majumdar 07-08-2020

Immunomedics to Participate in Upcoming Healthcare Conferences

By Marketwired Marketwired 09-02-2020